DOJ cuts deferred prosecution deal with bankrupt pharma
The Department of Justice’s antitrust division has charged Rising Pharmaceuticals with conspiring to fix prices and allocate customers for a generic hypertension drug, but resolved the charge with a deferred prosecution agreement.
Subscribe to Global Competition Review
Subscribe and start reading now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10